A large study from Germany suggests that a readily available medication, Actos (Pioglitazone) may prevent Alzheimer’s disease from developing in diabetic patients, reducing their risk by 50%.
This study, looked at the records over 150,000 patients and the connection between taking Actos long term, and reduced Alzheimer’s risk, was substantial…about 50%.
This medication had been controversial int he past, in treating diabetes because of it’s questionable association with bladder cancer. Subsequent studies have demonstrated NO CONNECTION WITH BLADDER CANCER, and with this new data, there is reason to show renewed interest in this medication.
Read more >>>HERE<<<<